Related Experiment Videos
Diazepam in high doses is effective in schizophrenia
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1982
Summary
High-dose diazepam significantly reduced positive and negative symptoms in paranoid schizophrenic patients. This double-blind study found rapid symptom elimination in most participants treated with diazepam.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Neuroscience
Background:
- Schizophrenia is a severe mental disorder characterized by positive and negative symptoms.
- Current treatments for schizophrenia have limitations and side effects.
- Benzodiazepines, like diazepam, are anxiolytics with potential psychotropic effects.
Purpose of the Study:
- To investigate the efficacy of high-dose diazepam in treating paranoid schizophrenia.
- To assess the impact of diazepam on both positive and negative schizophrenic symptoms.
Main Methods:
- A double-blind, placebo-controlled study was conducted.
- High doses of diazepam (up to 400 mg/day) were administered to paranoid schizophrenic patients.
- Symptom severity was evaluated using multiple validated scales: BPRS, CGI, SS-PSE, SARS, NOSIE, and SCL-90.
Main Results:
- Dramatic elimination of both positive symptoms (hallucinations, delusions) and negative symptoms (withdrawal, blunted affect) was observed.
- Symptom reduction occurred rapidly, within hours to days of initiating diazepam treatment.
- Five out of six patients experienced significant symptom improvement.
Conclusions:
- High-dose diazepam demonstrates rapid and significant efficacy in alleviating both positive and negative symptoms of paranoid schizophrenia.
- Diazepam may represent a valuable therapeutic option for acute management of schizophrenic symptoms.
- Further research is warranted to explore long-term efficacy and safety profiles.